Replies to post #41320 on MultiCell Technologies Inc (MCET)

[simon wagstaff]

I will just point out once again that the patent for MCT-125, licensed from Amarin many years ago, with zero activity, will expire in the next few years. There is not enough time to run the trials, get approval and market the drug. Not a chance. Just more MCET smoke.